Margaret G. Mcglynn - Mar 4, 2024 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Mar 4, 2024
Transactions value $
-$158,175
Form type
4
Date filed
3/6/2024, 05:21 PM
Previous filing
Jun 13, 2023
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $21K +7.5K +12.65% $2.80 66.8K Mar 4, 2024 Direct
transaction FOLD Common Stock Sale -$99.7K -7.5K -11.23% $13.29 59.3K Mar 4, 2024 Direct
transaction FOLD Common Stock Options Exercise $21K +7.5K +12.65% $2.80 66.8K Mar 5, 2024 Direct
transaction FOLD Common Stock Sale -$101K -7.5K -11.23% $13.40 59.3K Mar 5, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -7.5K -50% $0.00 7.5K Mar 4, 2024 Common Stock 7.5K $2.80 Direct F1
transaction FOLD Stock Options (right to buy) Options Exercise $0 -7.5K -100% $0.00* 0 Mar 5, 2024 Common Stock 7.5K $2.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 All of the options were fully vested and exercisable as of the transaction date.

Remarks:

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.